No products in the cart.
Emraclidine is safe and well-tolerated for the treatment of schizophrenia
1. Incidence of total adverse events and specific adverse events were similar between the emraclidine groups and placebo. 2. There ...
Tag: schizophrenia
Excitatory noninvasive brain stimulation interventions improved negative symptoms in schizophrenia
1. Excitatory Noninvasive Brain Stimulation Intervention (NIBS) protocols over the left dorsolateral prefrontal cortex were associated with significantly large improvements ...
Variation in antipsychotic medication responsiveness present amongst schizophrenia patients
1. In this study, both individual patient and study-level analyses revealed a negative correlation between placebo response and treatment effect, ...
Majority of long-acting injectable and oral antipsychotics are similar in efficacy for schizophrenia maintenance therapy
1. There was no evidence of superiority among the different antipsychotics. 2. Choice of antipsychotic regimen for schizophrenia maintenance should ...
Survivors of intensive care unit admissions may have increased risk of self-harm and suicide
1. Patients with prior episodes of critical illness requiring ICU admission were found to have an elevated risk of suicide ...
Xanomeline-trospium treatment showed improvement in patients with schizophrenia
1. Xanomeline-trospium treatment showed a greater reduction in the degree of psychosis in patients with schizophrenia compared to placebo. 2. ...
Association of recent stressful life events with mental and physical health in the context of genomic and exposomic liability for schizophrenia
1. Environmental liability for schizophrenia moderated the association of stressful life events with mental and physical health. Evidence Rating Level: ...
2 Minute Medicine Rewind August 31, 2020
Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors 1. Hyperthyroidism was associated with a higher ...
#VisualAbstract: A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia
1. An oral compound, SEP-363856 was shown to significantly reduce the total score of the Positive and Negative Symptom Scale ...
Abnormal cellular metabolism and neuronal pathways in organoids developed from schizophrenic patients
1. In this study of 3-dimensional cerebral organoids of schizophrenia patients and healthy controls, differences were found in mitochrondrial function, ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.